532488:BOM
Divi's Laboratories Ltd
₹9.220,00
arrow_upward
+1,99%(+180,05) 1D
16 ຕ.ລ., 15 ໂມງ 56 ນາທີ 15 ວິນາທີ GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532488...
Open
₹9.013,35
High
₹9.247,50
Low
₹8.985,00
Mkt. cap
2,45 ລ້ານລ້ານ
Avg. vol.
33,69 ພັນ
Volume
17,22 ພັນ
Dividend
0,33%
Quarterly dividend
₹7,50
Ex-dividend date
24 ກ.ລ. 2026
P/E ratio
83,67
52-wk high
₹10.000,00
52-wk low
₹5.648,00
EPS
₹110,20
Shares outstanding
265,47 ລ້ານ
No. of employees
12 ພັນ
Open
₹9.013,35
High
₹9.247,50
Low
₹8.985,00
Mkt. cap
2,45 ລ້ານລ້ານ
Avg. vol.
33,69 ພັນ
Volume
17,22 ພັນ
Dividend
0,33%
Quarterly dividend
₹7,50
Ex-dividend date
24 ກ.ລ. 2026
P/E ratio
83,67
52-wk high
₹10.000,00
52-wk low
₹5.648,00
EPS
₹110,20
Shares outstanding
265,47 ລ້ານ
No. of employees
12 ພັນ
News stories
From web sources and news partners
Investor's Business Daily
·
49 ນາທີກ່ອນ
Stock Market Ends Week With Software Sell-Off; Nasdaq Dives 2%, Gives Up 200-Day Line
MarketWatch
·
1 ຊົ່ວໂມງກ່ອນ
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Stocktwits
·
12 ນາທີກ່ອນ
Nasdaq 100 Records Worst Week In 18 Months As Investors Steer Clear Of Chipmakers — AAPL, MSTR, UBER, SOXX In Focus
CNN
·
3 ຊົ່ວໂມງກ່ອນ
Nasdaq sinks more than 2% as investors raise questions about AI debt
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd
CEOKiran S. Divi
Employees11,6 ພັນ
Founded12 ຕ.ລ. 1990
Headquarters-
SectorHealth care
Websitedivislabs.com